Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 7/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5164866 | 0.82 | — | — | |
| SCHEMBL45380 | 0.78 | DNM1 (0.38) | DNM1CA2MAPK1CA1ALDH1A1 | |
| SCHEMBL23825091 | 0.76 | FDPS (0.38) | DNM1CA2MAPK1CA1ALDH1A1 | |
| SCHEMBL22398662 | 0.74 | DNM1 (0.35) | DNM1CA2CA1ALDH1A1MAPT | |
| SCHEMBL833676 | 0.74 | DNM1 (0.35) | DNM1CA2CA1ALDH1A1MAPT | |
| SCHEMBL23825068 | 0.74 | FDPS (0.36) | DNM1CA2MAPK1CA1ALDH1A1 | |
| SCHEMBL578359 | 0.74 | ALDH1A1 (0.36) | DNM1CA2MAPK1CA1ALDH1A1 | |
| SCHEMBL23825077 | 0.74 | FDPS (0.36) | DNM1CA2MAPK1CA1ALDH1A1 | |
| SCHEMBL45136 | 0.74 | DNM1 (0.35) | DNM1CA2MAPK1CA1ALDH1A1 | |
| SCHEMBL28292487 | 0.74 | DNM1 (0.35) | DNM1CA2CA1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190233738-A1 | PROCEDURE FOR THE REMOVAL OF FLUORIDATED POLLUTANTS FROM HYDROCARBON EFFLUENTS | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2019-08-01 | — | — | US | disclosed |
| US-20170290333-A1 | PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | CORTEVA AGRISCIENCE LLC | 2017-10-12 | — | — | US | disclosed |
| EP-1177038-A4 | METHOD FOR REDUCING ORGANIC FLUORIDE LEVELS IN HYDROCARBONS | CONOCOPHILLIPS CO (US) | 2007-02-21 | — | — | EP | disclosed |
| US-6878350-B2 | Method for reducing organic fluoride levels in hydrocarbons | CONOCOPHILLIPS COMPANY (US) | 2005-04-12 | — | — | US | disclosed |
| US-20020185413-A1 | Method for reducing organic fluoride levels in hydrocarbons | PHILLIPS PETROLEUM COMPANY (US) | 2002-12-12 | — | — | US | disclosed |
| US-6426441-B1 | CONTACTING A VOLATILITY REDUCING ADDITIVE AND HYDROFLUORIC ACID CATALYST WITH HYDROCARBON MIXTURE IN AN ALKYLATION ZONE, PHASE SEPARATING, OCTANCE NUMBER OF 85-98 | PHILLIPS PETROLEUM COMPANY | 2002-07-30 | — | — | US | disclosed |
| US-6423211-B1 | EDUCTING INTO A HYDROCARBON MIXTURE A CATALYST OF A VOLATILITY REDUCING ADDITIVE AND HYDROFLUORIC ACID, WHICH UNDERGOES PHASE SEPARATION; CONTROLLING RESEARCH OCTANE NUMBER | PHILLIPS PETROLEUM COMPANY | 2002-07-23 | — | — | US | disclosed |
| EP-1177038-A1 | METHOD FOR REDUCING ORGANIC FLUORIDE LEVELS IN HYDROCARBONS | Phillips Petroleum Company (US) | 2002-02-06 | — | — | EP | disclosed |
| US-6114593-A | A PHASE SEPARATION WITH A VOLATILITY REDUCING ADDITIVE AND HYDROFLUORIC ACID | PHILLIPS PETROLEUM COMPANY (US) | 2000-09-05 | — | — | US | disclosed |
| WO-2000044489-A1 | METHOD FOR REDUCING ORGANIC FLUORIDE LEVELS IN HYDROCARBONS | PHILLIPS PETROLEUM COMPANY (US) | 2000-08-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170290333-A1 | PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | PFAS, CASP2, CYP1A2 | DNM1 3246/4885CA2 247/4885MAPK1 3589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.